HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Nai-Kong V Cheung Selected Research

Neuroblastoma

11/2015A dual-specific anti-IGF-1/IGF-2 human monoclonal antibody alone and in combination with temsirolimus for therapy of neuroblastoma.
6/2015Osteochondroma in long-term survivors of high-risk neuroblastoma.
3/2015Disialoganglioside GD2 as a therapeutic target for human diseases.
3/2015Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy.
3/2015Retargeting T cells to GD2 pentasaccharide on human tumors using Bispecific humanized antibody.
1/2015Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy.
1/2015Immunotherapy of Childhood Sarcomas.
11/2014Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma.
10/2014Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis.
4/2014Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Nai-Kong V Cheung Research Topics

Disease

74Neuroblastoma
11/2015 - 05/2002
59Neoplasms (Cancer)
12/2015 - 05/2002
9Neoplasm Metastasis (Metastasis)
11/2015 - 11/2005
6Residual Neoplasm
03/2015 - 10/2003
6Melanoma (Melanoma, Malignant)
03/2015 - 11/2002
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2015 - 03/2003
4Osteosarcoma (Osteogenic Sarcoma)
03/2015 - 02/2004
4Sarcoma (Soft Tissue Sarcoma)
01/2015 - 02/2004
4Lymphoma (Lymphomas)
01/2015 - 11/2002
3Neuroectodermal Tumors (Neuroectodermal Tumor)
05/2015 - 10/2004
3Rhabdomyosarcoma
03/2015 - 10/2005
3Retinoblastoma (Glioblastoma, Retinal)
03/2015 - 01/2013
2Liposarcoma
03/2015 - 01/2014
2Glioma (Gliomas)
03/2015 - 12/2008
2Leiomyosarcoma
03/2015 - 01/2014
2Fibrosarcoma
03/2015 - 01/2014
2Pain (Aches)
01/2014 - 03/2011
2Brain Neoplasms (Brain Tumor)
01/2014 - 01/2013
2Hypothyroidism
07/2010 - 05/2010
2Leukemia
07/2009 - 11/2003
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2009 - 10/2008
2Carcinoma (Carcinomatosis)
01/2005 - 11/2002
1Osteochondroma (Osteocartilaginous Exostosis)
06/2015
1Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2014
1Ewing's Sarcoma (Sarcoma, Ewing)
01/2014
1Headache (Headaches)
08/2013
1Hypertension (High Blood Pressure)
08/2013

Drug/Important Bio-Agent (IBA)

16AntigensIBA
12/2015 - 06/2002
11Immunoglobulin G (IgG)IBA
12/2015 - 05/2002
11Monoclonal AntibodiesIBA
06/2015 - 11/2002
10GD2 gangliosideIBA
05/2015 - 06/2002
8Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2014 - 07/2003
7AntibodiesIBA
05/2015 - 03/2003
6Complement System Proteins (Complement)IBA
05/2015 - 07/2004
5Bispecific AntibodiesIBA
08/2015 - 01/2014
5Topotecan (Hycamtin)FDA LinkGeneric
03/2011 - 08/2003
5irinotecan (Camptosar)FDA LinkGeneric
03/2011 - 01/2004
5Vincristine (Oncovin)FDA LinkGeneric
01/2011 - 01/2004
5Messenger RNA (mRNA)IBA
02/2010 - 06/2002
5(N- acetylneuraminyl)- galactosylglucosylceramide N-acetylgalactosaminyltransferaseIBA
02/2010 - 06/2002
4Isotretinoin (Accutane)FDA LinkGeneric
06/2015 - 07/2003
43-Iodobenzylguanidine (Iobenguane)IBA
11/2014 - 03/2003
4DNA (Deoxyribonucleic Acid)IBA
12/2013 - 04/2007
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2011 - 01/2004
3monoclonal antibody 8H9IBA
12/2015 - 10/2005
3Antigen Receptors (Antigen Receptor)IBA
08/2015 - 01/2014
3Surface Antigens (Surface Antigen)IBA
06/2015 - 12/2002
3temozolomide (Temodar)FDA LinkGeneric
03/2011 - 11/2006
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2007 - 03/2003
3Complement C3b (C3bi)IBA
06/2005 - 05/2002
3polyglucosanIBA
06/2005 - 05/2002
2HLA Antigens (Human Leukocyte Antigens)IBA
08/2015 - 03/2015
23F8 antibodyIBA
03/2015 - 07/2003
2Neoplasm Antigens (Tumor Antigens)IBA
01/2015 - 01/2005
2MicroRNAs (MicroRNA)IBA
10/2014 - 08/2009
2GangliosidesIBA
03/2014 - 02/2010
2Immunotoxins (Immunotoxin)IBA
01/2014 - 02/2004
2Immunoglobulins (Immunoglobulin)IBA
08/2013 - 12/2008
2Carboplatin (JM8)FDA LinkGeneric
02/2013 - 03/2011
2Etoposide (VP 16)FDA LinkGeneric
02/2013 - 07/2006
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
03/2012 - 08/2003
2Tumor Suppressor Protein p14ARF (p14ARF)IBA
10/2011 - 02/2010
2RNA (Ribonucleic Acid)IBA
02/2010 - 03/2003
2DNA-Binding Proteins (DNA Binding Protein)IBA
01/2010 - 03/2003
2Cyclin D1IBA
12/2007 - 04/2007
2Cisplatin (Platino)FDA LinkGeneric
07/2006 - 09/2005
2beta-GlucansIBA
06/2005 - 11/2002
2Immunoconjugates (Immunoconjugate)IBA
01/2005 - 10/2004
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
07/2003 - 05/2002
2Biological Markers (Surrogate Marker)IBA
03/2003 - 05/2002
1Insulin-Like Growth Factor I (IGF-1)IBA
11/2015
1Somatomedins (Somatomedin)IBA
11/2015
1temsirolimusFDA Link
11/2015
1Insulin-Like Growth Factor II (Somatomedin A)IBA
11/2015
1Dihydrotachysterol (AT 10)IBA
06/2015
1Radioisotopes (Radionuclides)IBA
06/2015
1Interleukin-2 (IL2)IBA
03/2015
1CytokinesIBA
03/2015
1Cancer VaccinesIBA
01/2015
1Guanidine (Guanidine Nitrate)FDA Link
11/2014
1Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
04/2014
13-fluorobenzylguanidineIBA
04/2014
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
03/2014
1Blocking AntibodiesIBA
01/2014
1IfosfamideFDA LinkGeneric
02/2013
1IceIBA
02/2013
1Amino AcidsFDA Link
01/2013
1LigandsIBA
09/2012
1Formaldehyde (Formol)FDA Link
03/2012
1ParaffinIBA
03/2012
1JM 3100FDA Link
03/2012

Therapy/Procedure

24Immunotherapy
08/2015 - 12/2002
21Drug Therapy (Chemotherapy)
11/2015 - 09/2002
14Heterologous Transplantation (Xenotransplantation)
12/2015 - 05/2002
9Radioimmunotherapy
12/2015 - 03/2003
6Radiotherapy
06/2015 - 07/2003
3Aftercare (After-Treatment)
07/2010 - 07/2003
2Therapeutics
01/2014 - 03/2009
2Biological Therapy
10/2003 - 09/2002
1Hematopoietic Stem Cell Mobilization
03/2012